Serum osteocalcin in subjects with metabolic syndrome and central obesity

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 10, Issue 1, 2016, Pages S42-S45

  Bador, Khalidah M ^a   Wee, Lim D ^a   Halim, Siti Aizon A ^a   Fadi, Mohd Faris M ^a   Santhiran, Premalatha ^a   Rosli, Nabila F ^a   Mustafa, Norlaila ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Adiposity; Central obesity; Diabetes; Metabolic syndrome; Osteocalcin

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; OSTEOCALCIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; ANTIHYPERTENSIVE AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; YOUNG ADULT; ABDOMINAL OBESITY; BLOOD; COMPLICATION; IMPAIRED GLUCOSE TOLERANCE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ANTIHYPERTENSIVE THERAPY; GLUCOSE LEVEL; HYPERTENSION; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; OSTEOCALCIN; PREDIABETIC STATE;

EID: 84996497090     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2015.09.009     Document Type: Article

References (22)

1. [1] Lee, N.K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J.D., Confavreux, C., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 130 (2007), 456–469.
2. [2] Ferron, M., Hinoi, E., Karsenty, G., Ducy, P., Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 105 (2008), 5266–5270.
3. [3] Saleem, U., Mosley, T.H. Jr., Kullo, I.J., Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 30 (2010), 1474–1478.
4. [4] Yeap, B.B., Chubb, S.A.P., Flicker, L., McCaul, K.A., Ebeling, P.R., Beilby, J.P., et al. Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur J Endocrinol 163 (2010), 265–272.
5. [5] Bae, S., Choe, J., Chung, Y.E., Kim, B.J., Lee, S., Kim, H., et al. The association between serum osteocalcin levels and metabolic syndrome in Koreans. Osteoporos Int 22 (2011), 2837–2846.
6. [6] Tan, A., Gao, Y., Yang, X., Zhang, H., Qin, X., Mo, L., et al. Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population survey. Metabolism 60 (2011), 1186–1192.
7. [7] Im, J.A., Yu, B.P., Jeon, J.Y., Kim, S.H., Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chim Acta 396 (2008), 66–69.
8. [8] Zhou, M., Ma, X., Li, H., Pan, X., Tang, J., Gao, Y., et al. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J Endocrinol 161 (2009), 723–729.
9. [9] García-Martín, A., Cortés-Berdonces, M., Luque-Fernández, I., Rozas-Moreno, P., Quesada-Charneco, M., Muñoz-Torres, M., Osteocalcin as a marker of metabolic risk in healthy postmenopausal women. Menopause 18 (2011), 537–541.
10. [10] Pittas, A.G., Harris, S.S., Eliades, M., Stark, P., Dawson-Hughes, B., Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 94 (2009), 827–832.
11. [11] Alberti, K.G., Zimmet, P., Shaw, J., Metabolic syndrome – a new world-wide definition: a consensus statement from the International Diabetes Federation. Diabet Med 23 (2006), 469–480.
12. [12] Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972), 499–502.
13. [13] Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985), 412–419.
14. [14] American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 33:Suppl. 1 (2010), S62–S69.
15. [15] Fernandez-Real, J.M., Izquierdo, M., Ortega, F., Gorostiaga, E., Gomez-Ambros, J., Moreno-Navarrete, J.M., et al. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 94 (2009), 237–245.
16. [16] Bezerra dos Santos Magalhães, K., Magalhães, M.M., Diniz, E.T., Lucena, C.S., Griz, L., Bandeira, F., Metabolic syndrome and central fat distribution are related to lower serum osteocalcin concentrations. Ann Nutr Metab 62 (2013), 183–188.
17. [17] Lee, S.W., Jo, H.H., Kim, M.R., You, Y.O., Kim, J.H., Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women. Gynecol Endocrinol 28 (2012), 472–477.
18. [18] Chan, M.H., Mak, T.W., Chiu, R.W., Chow, C.C., Chan, I.H., Lam, C.W., Simvastin increases serum osteocalcin concentration in patients treated for hypercholesterolaemia. J Clin Endocrinol Metab 86 (2001), 4556–4559.
19. [19] Winhofer, Y., Handisurya, A., Tura, A., Bittighofer, C., Klein, K., Schneider, B., et al. Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diabetes Care 33 (2010), 139–143.
20. [20] Aoki, A., Muneyuki, T., Yoshida, M., Munakata, H., Ishikawa, S.E., Sugawara, H., et al. Circulating osteocalcin is increased in early-stage diabetes. Diabetes Res Clin Pract 92 (2011), 181–186.
21. [21] Hwang, Y.C., Jee, J.H., Jeong, I.K., Ahn, K.J., Chung, H.Y., Lee, M.K., Circulating osteocalcin level is not associated with incident type 2 diabetes in middle-aged male subjects: mean 8.4-year retrospective follow-up study. Diabetes Care 35 (2012), 1919–1924.
22. [22] Ngarmukos, C., Chailurkit, L.O., Chanprasertyothin, S., Hengprasith, B., Sritara, P., Ongphiphadhanakul, B., A reduced serum level of total osteocalcin in men predicts the development of diabetes in a long-term follow-up cohort. Clin Endocrinol 77 (2012), 42–46.